|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0205131,
umls-concept:C0231448,
umls-concept:C0332283,
umls-concept:C0439230,
umls-concept:C0547043,
umls-concept:C0574960,
umls-concept:C0949690,
umls-concept:C1122087,
umls-concept:C1274040,
umls-concept:C1704788
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2008-7-15
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To evaluate the efficacy and safety of the tumor necrosis factor (TNF) antagonist adalimumab in patients with axial spondylarthritis (SpA) without radiographically defined sacroiliitis refractory to conventional treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1981-91
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18576337-Adult,
pubmed-meshheading:18576337-Anti-Inflammatory Agents,
pubmed-meshheading:18576337-Antibodies, Monoclonal,
pubmed-meshheading:18576337-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:18576337-Double-Blind Method,
pubmed-meshheading:18576337-Female,
pubmed-meshheading:18576337-Humans,
pubmed-meshheading:18576337-Male,
pubmed-meshheading:18576337-Middle Aged,
pubmed-meshheading:18576337-Sacroiliac Joint,
pubmed-meshheading:18576337-Spondylarthritis,
pubmed-meshheading:18576337-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two.
|
|
pubmed:affiliation |
Charité Medical University Hospital, Campus Benjamin Franklin, Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
